Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

July 30, 2020July 30, 2020

Thread-based Wearable Device May Help Diagnose, Monitor CF and Other Conditions

cystic fibrosis, News

Researchers have developed the first thread-based flexible patch that can be sewn into clothing to monitor — in real time — several molecules in sweat, including chloride ions, which ... Read more

July 7, 2020July 7, 2020

Common P. aeruginosa Mutations May Lead to Biofilm Growth, Bacterial Persistence, Study Says

News

The common mutations that cause Pseudomonas aeruginosa to lose their ability to move are associated with a higher production of two complex sugar molecules implicated in the formation of ... Read more

June 9, 2020June 15, 2020

Suppressing Function of Chloride Channel TMEM16A Eyed as Potential Therapeutic Approach

cystic fibrosis, News

Researchers have reported the case of two siblings with impaired CFTR function due to a deficiency in another chloride channel, called TMEM16A, that do not present symptoms associated with ... Read more

April 17, 2020April 17, 2020

Protein Called TAS2R38 Linked to Respiratory Tract Complications in CF

cystic fibrosis, News

Problems with a protein called TAS2R38 are linked to a greater risk of severe sinonasal disease and Pseudomonas aeruginosa lung infections early in life in people with cystic fibrosis (CF), a study ... Read more

April 8, 2020April 8, 2020

More Training Needed in CF End-of-life Care, Small UK Survey Shows

cystic fibrosis, News

Most healthcare professionals are not fully prepared for cystic fibrosis (CF) end-of-life care, and further training and coordination between CF and palliative care teams would be helpful, according to a ... Read more

February 14, 2020May 6, 2020

Iron Deficiency Common Among CF Patients and Requires Routine Screening and Guidelines, Study Suggests

cystic fibrosis, News

Iron deficiency is common among adults with stable cystic fibrosis (CF) and is significantly associated with anemia, vitamin A deficiency, antacids use, and moderate to severe lung disease, a ... Read more

January 31, 2020January 31, 2020

S. pseudopneumoniae Bacteria Can Cause Pulmonary Exacerbations in CF Patients, Study Finds

cystic fibrosis, News

Streptococcus pseudopneumoniae should be included in the panel of opportunistic bacteria causing pulmonary exacerbations among those with cystic fibrosis (CF), according to a small French study. The study, “Streptococcus ... Read more

January 21, 2020January 22, 2020

Enterprise’s ETX001 Targeting Chloride Channel Shows Promise for CF in Preclinical Studies

cystic fibrosis, News

Enterprise Therapeutics‘ experimental compound called ETX001 was able to increase airway fluid secretion and mucus clearance in preclinical models of cystic fibrosis (CF), a study reports. ETX001 is a ... Read more

November 20, 2019November 20, 2019

CF-related Diabetes Affects Girls More Often and at Younger Age than Boys, European Study Shows

cystic fibrosis, News

Girls with cystic fibrosis-related diabetes (CFRD) are exposed to risk factors of early death — including chronic infections, poor lung function, and poor nutrition — at a significantly higher proportion and ... Read more

November 7, 2019November 7, 2019

Eloxx Presents Positive Preclinical and Clinical Data of CF Therapy Candidate ELX-02

cystic fibrosis, News

Eloxx Pharmaceuticals presented additional positive preclinical and clinical data for ELX-02, its lead treatment candidate for cystic fibrosis (CF), reinforcing the therapy’s safety and tolerability in humans and its ability to increase ... Read more